|
浅析我国中医药知识产权保护的问题与对策
|
Abstract:
中医药是中华民族传统医药的瑰宝,具有悠久的历史和深厚的文化底蕴。但是,近年来的数据显示,我国中医药知识产权保护面临着诸多风险挑战。当前,我国中医药知识产权保护存在着中医药知识产权保护意识缺乏、中医药知识产权保护制度体系尚不完善、中医药知识产权保护的国内和国际衔接不到位的问题。究其原因,是由重视西药技术而忽视中医药特别是公知领域内瑰宝中医药、中医药保护体系同源自西方的知识产权知识技术体系不同、中医药知识产权具有鲜明中国特色难以自行适应国际市场所造成。针对前述问题,可采取增强中医药知识产权保护意识、完善中医药知识产权保护制度体系、积极主导参与中医药知识产权保护国际立法并加强衔接的策略。
Traditional Chinese medicine (TCM) is a treasure of traditional Chinese healthcare, endowed with a long history and profound cultural heritage. However, recent data indicates that the protection of intellectual property rights (IPR) for TCM in our country is facing numerous risks and challenges. Currently, there are issues such as a lack of awareness regarding the protection of TCM IPR, an incomplete system of IPR protection regulations for TCM, and inadequate domestic and international coordination in TCM IPR protection. The reasons for these issues include a focus on Western pharmaceutical technology at the expense of TCM, especially the treasures of traditional Chinese medicine within the publicly recognized domain, differences between the TCM protection framework and the Western-originated IPR knowledge and technology system, as well as the distinct Chinese characteristics of TCM IPR that make it difficult to adapt spontaneously to the international market. In response to these problems, strategies could be adopted such as enhancing awareness of TCM IPR protection, improving the system of TCM IPR protection regulations, actively leading and participating in international legislation concerning TCM IPR protection, and strengthening coordination efforts.
[1] | 周时更, 许方泳, 魏晋才. 我国传统医药知识产权专利申请与授权分析[J]. 医学与社会, 2017, 30(4): 60-63. |
[2] | 夏松柏, 杜光, 张聪子, 等. 我国中药知识产权保护现状与对策[J]. 时珍国医国药, 2016, 27(10): 2524-2525. |
[3] | 钱静华, 郭志丽. 构建适合中医药特征的临床证据评价体系[J]. 中华中医药杂志, 2018, 33(10): 4302-4304. |
[4] | 邓鑫, 刘丽静, 许克祥. 《中医药法》下中药知识产权保护现状分析及策略[J]. 中国卫生法制, 2022, 30(4): 23-37. |
[5] | 李和伟, 王启帆, 付宇, 等. 中医防控慢性病的优势与发展思考[J]. 中华中医药杂志, 2018, 33(11): 4821-4823. |
[6] | 李一丁. 论传统中医药知识专门法律保护的几个问题[J]. 中国卫生法制, 2016, 25(4): 14-17. |
[7] | 曾彤, 高天, 李成蹊, 等. 中药知识产权的法律保护[M]. 成都: 四川大学出版社, 2015. |
[8] | 何文威, 李野, 洪兰. 日本药品专利战略浅析及对我国的启示[J]. 中国药房, 2006(12): 887-889. |
[9] | 李慧, 宋晓亭. 中药品种保护制度的法律性质[J]. 中草药, 2018, 49(2): 499-504. |
[10] | 马永剑, 高志红. 我国中药知识产权保护现状研究[J]. 内蒙古科技与经济, 2017(14): 12-14. |
[11] | 何京, 王磊, 田侃, 等. 从中药保护现状看我国的中药知识产权制度[J]. 国际中医中药杂志, 2016, 38(6): 492-495. |
[12] | 杨显滨. CBD与TRIPs协议冲突视野下公知中药配方的知识产权保护[J]. 政法论丛, 2017, 33(1): 112-122. |